Future therapeutic approaches may involve intervention in the early phase of wound healing, or in pathological skin conditions like psoriasis, by chemical or physical means to interfere with either target proteins like DNAH10, axonemal signaling, or with signaling cascades. Here, DNAH10 is linked to psoriasis.